Back

Glucagon-like peptide-1 receptor agonists and sodium glucose cotransporter-2 inhibitors combination therapy after acute myocardial infarction in patients with type 2 diabetes mellitus: a dynamic duo

1 September 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in coronary artery disease (2) Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Marin Vidak

University Hospital Dubrava, Zagreb (Croatia)

6 More presentations in this session

Presentation thumbnail
Combination therapy rapidly improves symptoms and quality of life in recently diagnosed angina patients: the COMBINE Angina study
Professor M. Marzilli (Pisa, IT)
Abstract Slides
Presentation thumbnail
Efficacy and safety of selective serotonin reuptake inhibitors on cardiovascular outcomes of patients with post-acute coronary syndrome depression: a systematic review and meta-analysis
Doctor J. Magno (Angeles City, PH)
Abstract Slides
Presentation thumbnail
Efficacy of PCSK9 inhibitors combined with statins versus statin monotherapy for secondary cardiovascular prevention: a systematic review and meta-analysis
Mr M. Lang (Pilar, AR)
Abstract Slides Video
Presentation thumbnail
Colchicine in acute coronary syndromes: a meta-analysis of 12.602 patients
Associate Professor G. Liuzzo (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Association of colchicine with atrial fibrillation and safety outcomes in patients with acute coronary syndrome
Doctor M. Tao (Hartford, US)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in coronary artery disease (2)

The Event

Event poster

ESC Congress 2025

1 September 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Early SGLT2i therapy in patients with T2DM and ACS results in reduction in cardiovascular and renal outcomes- a propensity score matched multi-model retrospective registry analysis
thumbnail
Congress Presentation
Glucose lowering drugs with proven cardiovascular benefit following acute coronary syndrome in type 2 diabetes: treatment gaps and outcomes
thumbnail
Congress Presentation
Baseline characteristics and clinical outcomes of patients with type 2 diabetes and cardiovascular disease treated with GLP-1 receptor agonists and SGLT2 inhibitors

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources